Australian parental decisions about transitioning children from booster seats in a randomised trial: greater support may be needed
Injury Prevention · 2025
DOI: 10.1136/ip-2023-045207 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Injury Prevention, 2025. Verfasst von Stacie Powell und 7 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia spowell@georgeinstitute…. Hauptthemen laut MEDLINE: Parents, Child Restraint Systems, Seat Belts, Decision Making. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Australian Research Council, National Health and Medical Research Council.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Premature graduation to an adult seatbelt is common and detrimental to optimal crash protection. While there is an existing tool (the 5-step test ) to support a parent’s decision to graduate their child, its effectiveness is unknown. The aim of this study was to evaluate the 5-step test .
Method
A randomised controlled design was used. Participants were parents of children aged 7–12 years. After exposure to information about the 5-step test or control material, participants assessed belt fit in three seating conditions and ‘thought aloud’ while making their assessment. Seating conditions provided a good, poor and partially good seatbelt fit based on the child’s anthropometry. Participants were also assessed on their knowledge of good seatbelt fit criteria.
Results
Participants exposed to the 5-step test (n=18) had significantly improved their knowledge of the criteria required to achieve good seatbelt with, on average, 1.0 higher score in the 6-point assessment (95% CI 0.23 to 1.7, p=0.012) than those in the control group. There was also a greater percentage of participants in this group (44.4% intervention vs 27.8% control) who made accurate decisions about seatbelt fit, but this difference did not reach significance (OR 2.08, 95% CI 0.52 to 8.34).
Conclusion
The results demonstrate that the 5-step test is effective in improving knowledge but are inconclusive about its effectiveness in promoting accurate decision-making. However, the proportion of participants making accurate decisions in the intervention group remained low. This suggests that parents may require greater assistance than what is currently provided.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia spowell@georgeinstitute.org.au.
- The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
- Neuroscience Research Australia, Randwick, New South Wales, Australia.
- Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
ORCID-Profile: Stacie Powell, Tom Whyte
Förderung
- Australian Research Council
- National Health and Medical Research Council
Zitieren
APA
Powell, S., Dai, W., Ho, C., Albanese, B., Keay, L., Whyte, T., Bilston, L. E., & Brown, J. (2025). Australian parental decisions about transitioning children from booster seats in a randomised trial: greater support may be needed. Injury Prevention. https://doi.org/10.1136/ip-2023-045207
Vancouver
Powell S, Dai W, Ho C, Albanese B, Keay L, Whyte T, et al. Australian parental decisions about transitioning children from booster seats in a randomised trial: greater support may be needed. Injury Prevention. 2025. doi:10.1136/ip-2023-045207
BibTeX
@article{Powell2025,
author = {Powell, Stacie and Dai, Wennie and Ho, Catherine and Albanese, Bianca and Keay, Lisa and Whyte, Tom and Bilston, Lynne E and Brown, Julie},
title = {Australian parental decisions about transitioning children from booster seats in a randomised trial: greater support may be needed},
journal = {Injury Prevention},
year = {2025},
doi = {10.1136/ip-2023-045207}
}
EUVIMED